NARSAD: Research Center: Project Summary for David C. Henderson, M.D.

» Apply for a Grant
- FAQs
- Young Investigator
- Independent
Investigator
- Distinguished
Investigator
- Staglin Award

» Grantee List
- Young Investigators
- Independent
Investigators
- Distinguished
Investigators
- Staglin Awards

» Project Summaries

» Prizes
- Lieber Prize
- Falcone Prize
- Ruane Prize
- Goldman-Rakic Prize
- Freedman Award
- Klerman Award

» For Grantees
- Young Investigator
Fact Sheet
- Independent
Investigator
Fact Sheet
- Distinguished
Investigator
Fact Sheet
- Staglin Award
Fact Sheet

Project Summary

David C. Henderson, M.D. (Young Investigator 2001) of Massachusetts General Hospital, is assessing whether patients with quetiapine have abnormalities in glucose metabolism. Previous work suggests that clozapine may increase the risk of diabetes and impair insulin sensitivity. In the present study, schizophrenia patients treated with quetiapine will be compared with medication-free patients with regard to glucose tolerance, and multiple risk factors for diabetes will be examined.

Program Area: SCHIZOPHRENIA/PSYCHOTIC DISORDERS\Schizophrenia

Search Again

Announcements

2008/2009 NARSAD Grant Deadlines:

2008 Independent Investigator application deadline: March 5, 2008

2008 Young Investigator, 2008 Distinguished Investigator and 2008 Staglin Grantees Announced: March, 2008

2008 Distinguished Investigator Earliest Start Date: May 1, 2008

2009 Distinguished Investigator Award application deadline: May 15, 2008

2008 Young Investigator Earliest Start Date: July 1, 2008

2009 Young Investigator Award application deadline: July 25, 2008

2008 Independent Investigator Award Earliest Start Date: September 15, 2008

2008 Staglin Award Earliest Start Date: September 15, 2008

2009 Distinguished Investigator Earliest Start Date: May 1, 2009

2009 Young Investigator Earliest Start Date: July 1, 2009

NARSAD Award Winners

Colleen Ann McClung, Ph.D., UT Southwestern Medical Center at Dallas, 2005 & 2007 Young Investigator